Romlusevimab, CAS 2509447-08-7

Product Description: Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Hoy SM. Amubarvimab/Romlusevimab: First Approval. Drugs. 2022 Aug;82(12):1327-1331./[2]Ji Y, et al. Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Front Immunol. 2022 Sep 14;13:980435.

CAS Number: 2509447-08-7

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Infection

Solubility: H2O

Target: SARS-CoV

• Artikelnummer: MEXHY-P99889-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99889-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated